Stocks and Investing Stocks and Investing
Fri, December 4, 2020
Thu, December 3, 2020
Wed, December 2, 2020
Tue, December 1, 2020
Mon, November 30, 2020
Sun, November 29, 2020
Fri, November 27, 2020
Wed, November 25, 2020

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $203 on, Nov 25th, 2020


Published on 2024-10-27 14:52:26 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $200 to $203 on, Nov 25th, 2020.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold and Decreased Target to $156 on, Tuesday, August 11th, 2020


This is the rating of the analyst that currently disagrees with David


  • Joel Beatty of "Citigroup" Initiated at Strong Buy and Held Target at $170 on, Tuesday, September 8th, 2020